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Problems of Epidemiological Evidence*
Problems associated withthe use ofepidemiological
evidence to evaluate the carcinogenicity of metals
are, inthemain, thoseassociated withepidemiological
enquiry in general. There are, however, some
additional difficulties that arise from the variety of
ways in which exposure to metals can occur, the
variety of metal species and compounds, and the
frequency of mixed exposure. We shall, therefore,
review some of these problems, and the ways in
which they can be overcome, before reviewing the
evidence relating to individual elements.
One of the greatest difficulties is to obtain a
population for study that is large enough to distin-
guish the effects of a specific hazard from the
effects ofthe random variation ofsmall numbers or
alternatively to be confident that no material risk
exists, when negative results are obtained (the
problem of statistical power and its relation to
sample size). These cannot always be overcome by
increasing the size ofthe population, as the number
of people exposed to high concentrations of the
agent may be small and extension of the study to
include larger numbers will only dilute the results,
ifthe additional subjects have not been intensively
exposed. In studies of cancer, there is also the
problem that the first ten years after exposure to a
carcinogen seldom provide much evidence of risk.
Longer periods, even 30 years or more, may be
required before the existence of a risk can be
properly assessed, and the inclusion of large num-
bers ofsubjects who have been observed for only a
short period will serve to dilute the results still
further. The analysis should, therefore, be identified
whenever possible, both by intensity of exposure
and by length of time since exposure began.
The exact nature ofpast exposure atthe workplace
is often difficult to determine and, in the case of
exposure to metals, may be quite complex. Little
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information may be available on the previous expo-
sure ofindividual workers, and comparisons maybe
practicable onlybetweengroups ofworkersemployed
in particular occupations or on specific processes.
Sometimes, when measurements ofthe intensity of
past exposures are not available, these may have to
be estimated fromthe intensity ofcurrent exposure
in the same occupation orthe length ofemployment
may have to be used as a substitute for measure-
ment on the assumption that exposure has been
constant over time. Exceptionally, however, if
exposure was particularly heavy at a time when
labor turnover was high, duration of employment
can be dissociated from intensity of exposure and
paradoxical results may appear to be obtained.
A special problem in the study of metals is that
mixed exposures to more than one metal and to
different valencies or oxidation states of the metal
under investigation are frequent, and precise
specifications ofindividual components ofthe ambi-
ent pollution may not be available because of
limitations in the analytic method. Changes in the
nature of the process and in the consequent expo-
sure patterns may also have occurred over time
without being recognized.
Two other considerations which have to be taken
intoaccount aretheadequacy ofthe measure ofrisk
and the possible existence of confounding factors.
The endpoint that has most commonly been used in
studies ofmetal carcinogenesis is cancer mortality;
this is adequate for types of cancer with a high
fatality rate (e.g., cancer ofthe lung) but is a poor
measure forassessingthe riskofdevelopingtumors
with low fatality rates (e.g., cancer ofthe larynx).
Potential confounding factors such as personal
habits, socioeconomic status, and other occupa-
tional exposure are seldom taken adequately into
account due to lack ofinformation. Smoking habits
constitute one important confounding factor when
the hazard of lung cancer is being considered.
Differences in smoking habits are unlikely to be
large enough to account for a relative risk of lung
cancer more than twice that ofthe general popula-
tion, but inthe absence ofdetailedinformation, it is
a matter ofjudgment as to how far smaller relative
11risksthat are not dueto chance can be attributed to
excess smoking, exposure to the metal, or a com-
bined effect of both.
As with all other epidemiological studies, the
most important criterion forthe evaluation ofthose
relating to metal carcinogenesis is the consistency
oftheresults between studies (i.e., dotheyallpoint
in the same direction), within each individual study
(i.e., does the risk vary with the degree of expo-
sure), and with the results of laboratory tests
concerning carcinogenicity in animals and the ab-
sorption, distribution, metabolism and mechanism
ofaction ofthe metal under investigation. It must,
however, be borne in mind that there are many
ways in which apparent inconsistency can be pro-
duced, and it may be difficult to sort out how far it
can be due to differences in the design, method of
investigation, or analysis of the studies, or to
differences in the exposure of the subjects, or
biological variation. Positive results in one set of
circumstances are not necessarily contradicted by
negative results in another, nor vice versa. When
major inconsistencies prevent an unequivocal in-
terpretation of the totality ofthe data, this should
be regarded as constituting urgent grounds for
further research.
In the rest of our report we have considered in
detail the evidence relating to eight metals (in
alphabetical order) and follow this with a briefnote
on other metals. Specific recommendations concern-
ing individual metals and recommendations con-
cerning the detection of occupational hazards of
cancer in general are brought together at the end.
Arsenic
There is conclusive epidemiological evidence of
an increased risk oflung cancer in the manufacture
ofarsenic containing pesticides (1-3). The exposure
has been mainly to inorganic arsenic compounds.
No conclusions can be drawn with regard to the
carcinogenicity oftrivalent versus pentavalent com-
pounds as both forms have occurred in the circum-
stances in which individuals have been occupation-
allyexposed. Theuse ofarsenic-containing pesticides,
often as arsenates of low solubility, has been
associated with lung cancer among vintners in
Germany (4) and in France (5), but the data are not
conclusive.
The carcinogenicity ofinorganic, mainlytrivalent
arsenic is also evident from many epidemiological
studies of men employed in smelters (6-11). As a
rule, an increase in lung cancer mortality with
increasing dose of arsenic has been observed (6, 8,
10). It should be recognized that the smelter
environment is very complex, and the interaction
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between arsenic and other environmental pollu-
tants (SO2, heavy metals, etc.) as well as with
tobacco smoking is poorly understood.
Some studies haveindicated anincreased mortal-
ityfrom lungcancerin populations livingnearpoint
emission sources of arsenic to air (11), but the role
of arsenic cannot be assessed because of lack of
measurements ofexposure and effects ofconfounding
factors.
Exposure to inorganic arsenic can cause non-
melanotic skin cancer. This has been observed
following the ingestion ofarsenic in drinking water
and in arsenical medications in doses amounting to
several grams (12-15). The form of arsenic in the
drinking water has yet to be determined, but in
medication the evidence definitely relates to the
inorganic trivalent form (14).
Cases ofhemangioendothelioma ofthe liver have
been reported following exposure to inorganic ar-
senic from medicinal preparations (16-19), contami-
nated drinking water (20), and wine (21). The
evidence that arsenic was a causative factor in
these cases is thought to be conclusive.
A possible association between arsenic and can-
cerofothersites, mostnotablyofthelymphatic and
hematopoietic systems (2, 10), needs further inves-
tigation. No epidemiological data are available
relating to the carcinogenicity of organic arsenic
compounds.
Beryllium
Although numerous experimental studies had
indicated that a number of beryllium compounds
were carcinogenic in experimental animals by sev-
eral routes of administration (22), the results of
epidemiologic study up to the end of 1970 (23-26)
had not demonstrated any consistent evidence of
carcinogenicity in men and women employed in
primary beryllium production works, or among
subjects enrolled inthe U.S. Beryllium Case Regis-
try (BCR). Results of follow-up studies of these
populationsthroughthemid-1970'shavebeenrecently
reported (27-30). The study populations somewhat
overlap, as three reports concern the workers in
two factories (27-29), while the fourth concerns the
mortality of individuals in the Registry (30), many
ofwhomwere employed inthe same factories. Each
study demonstrates a significant excess of lung
cancer.
The lung cancer mortality observed in the beryl-
liumexposed workerswas excessive compared with
the mortality recorded forthe U.S. generalpopula-
tion (27) and that in a second industrial population
located in the same geographic region (29).
The studies demonstrate an excess lung cancer
Environmental Health Perspectivesrisk following short-term but heavy exposure to
beryllium (28). This same phenomenon was ob-
served for individuals who died from beryllium
disease, a clinical endpoint previously demonstrated
to be associated with occupational/environmental
exposure to beryllium (31). Our interpretation of
the total evidence is that beryllium is the cause of
the excess cancer mortality in these groups of
employees.
Cadmium
Occupational exposure to cadmium oxide fumes
occurs in the smelting and refining ofthe metal and
in the production of copper-cadmium and brazing
alloys. Exposure to cadmium oxide dust occurs in
cadmium-nickel battery manufacture and in the
production and use of cadmium oxide for plating,
chemical and plastics industries. Exposure to cad-
mium sulfide occurs inpigmentmanufacture. Lesser
exposures to cadmium stearates and other com-
pounds also occur. While cadmium has been used
increasingly in industry over the past 50 to 60
years, the total number of workers exposed to the
compounds ofthis metal has not been large. In the
earlier years ofcadmium usage, occupational expo-
sure was often heavy andprolonged, forneitherthe
fume nor the dust are highly irritant unless expo-
sure is massive. With the recognition of chronic
cadmium poisoning, many processes were redesigned
in the 1960's with enclosure and the installation of
exhaust ventilation. As aresult, occupational expo-
sure over the past 10-15 years has been greatly
reduced from concentrations measured in milli-
grams per cubic meter to levels measured in
micrograms per cubic meter.
The first intimation that cadmium might be a
human carcinogen came from a small study in
Britain ofmen exposed to cadmium oxide dust for a
minimum period of one year in cadmium-nickel
battery manufacture (32, 33), where there were
four deaths from carcinoma of the prostate when
less than one was expected. Exposure to cadmium
oxide dust had been heavy and had given rise to
chronic poisoning in the work force. In a similar-
sized group engaged for a minimum period of two
years on the refining of cadmium in the U.S., also
under heavy exposure conditions, four deaths from
prostate cancer were again observed, all of which
occurred more than 20 years after first exposure
(34). This number is significantly greater than that
expected (0.88) from national mortality statistics.
In this cohort there was also a significant excess of
lung cancer. However, smoking habits were not
determined, and there was concurrent exposure to
other compounds, in particular to arsenic. Concen-
trations ofarsenic were low when measured at the
time of the survey, but there is no information on
arsenic levels in the earlier years. In a Swedish
cadmium-nickel battery factory, where again heavy
exposure to cadmium oxide and nickel hydroxide
dusts had occurred in earlier years giving rise to
the first reported cases ofchronic cadmium poison-
ing, all workers with more than five years exposure
who developed cancer between 1959 and 1975 (35)
were identified. No significantexcessofprostatic or
lung cancer was found. Finally, in a Swedish
copper-cadmium alloy plant, a small increase in
prostatic cancer mortality, but not reaching a
significant level, was found in a group of workers
with at least five years heavy exposure to cadmium
oxide fume (35). In each of these studies the
number ofworkers investigated was small, with, in
all, 14 cases ofprostaticcanceragainst 5.4 expected.
The most reasonable interpretation of these re-
sults is that exposure to cadmium had contributed
to the development of prostatic cancer in the
exposed workers.t
Injection site sarcomata and interstitial cell tu-
mors of the testis have followed the injection of
several cadmium compounds (36-43). Prostatic tu-
mors have not been observed, but it is questionable
whether the animals studied provide adequate
models (44).
Chromium
An increased risk oflung cancer has been estab-
lished for workers in the primary chromate produc-
tion industry (45, 46). This increased risk has been
attributed to exposure to an incompletely defined
mixture ofchromates. An excess riskoflungcancer
has also been observed in workers in the chrome
pigment production industry (47, 48).
Secondary users of chromates other than the
chrome pigment industry and secondary users of
chrome pigments must be regarded as possibly
being at risk, but the epidemiological evidence (46,
49-51) is not conclusive.
Both results from the primary chromate produc-
tion industry and from chrome pigment production
are not inconsistent with the concept that slightly
soluble chromates are more carcinogenic than the
soluble compounds. Increased risk of lung cancer
has been reported in platers exposed to soluble
compounds (52), but the results in two studies
t One member ofthe Working Group dissociated himselffrom
this statement on the grounds that he considered the data
inadequate at the present time to reach such a conclusion.
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support the assumption that the slightly soluble
compounds arethe more active (56), butsoluble and
slightly soluble compounds are equally potent mu-
tagens in vitro (57, 58).
There is very little epidemiological evidence
relatingto workers exposed to trivalent chromium,
but such as there is does not suggest an increased
risk. A suggestion of an increased risk of lung
cancerin ferrochromium production canbe attributed
to exposure to hexavalent chromium in the process
(50). The assumption that exposure to trivalent
chromium does not constitute an increased risk of
cancer is indirectly supported by in vitro tests for
mutagenicity (59, 60) and by the observation that
only hexavalent chromium passes the cell mem-
brane (61), although the trivalent form may be the
active agent at the site of action (61-65).
No relation between dose and response can yet
be determined for the cancer causing effect of
hexavalent chromium in men. This is partly be-
cause the active agent in the actual circumstances
of exposure is unknown, and partly because only
limitedandunreliabledoseestimatescanbeobtained
forworkers whohave beenfound atriskforthe last
20-30 years. The importance of the chromium that
is found in tobacco for the development of lung
cancer is not known, nor is it known whether there
are synergistic effects between chromate exposure
and smoking. Some published data suggest an
increased risk of gastrointestinal cancer (52, 53,
66-69), but the results are inconclusive.
Cobalt
Occupational exposure to cobalt occurs in the
tungsten carbide hard metal industry, in mining
and refining of cobalt, in the production of cobalt
alloys, and in the handling of cobalt salts. Pulmo-
naryfibrosis has been reported in workers fromthe
hard metal industry (70, 71). Despite these exces-
sive exposures, there have been few reports of
cancer mortality occurring in these workers. One
epidemiological study of cobalt refinery workers
has reported an excess of deaths from lung cancer
(72). However, interpretation is complicated bythe
fact that there was also heavy exposure to arsenic,
mainly as arsenic trioxide, and probably also to
nickel. There are no convincing reports of cancer
arising from the use ofcobalt-containing prosthetic
devices in patients.
Finely divided cobaltmetalpowder, cobalt oxide,
and cobalt sulfide have produced fibrosarcoma (73)
t Some members of the Workdng Group felt that the results
were conclusive evidence of an increased risk in platers.
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and rhabdomyosarcoma (74) at injection sites in the
rat.
Cobalt, as the divalent ion, has been shown to
substitute for Mg2+ as an activator for DNA poly-
merase (75). Cobalt chloride has decreased the
fidelity of DNA synthesis in vitro (75, 76).
Iron
This most abundant metal in the earth's crust is
presentinits natural state in the formofoxidesand
carbonate. Occupational exposure, dating back to
prehistoric times, isboth commonand heavyiniron
ore mining, iron refining, steel production and
welding.
The injection of certain iron carbohydrate
complexes in large doses has been followed by local
sarcomaproduction in severalanimal species (77-82)
with evidence of a dose response relationship.
Millions ofdoses ofsuch complexes have beengiven
parenterally over the past 30 years in the treat-
ment ofiron deficiency anemia, but no more than a
handful of tumors at the site of injection (where
tumors are also known to occur spontaneously)
have been reported (83). In one study of all soft
tissue sarcomas which occurred over a defined
interval, no historyofparenteralirontherapycould
be obtained (84). In another study covering all
cases of sarcoma of the buttock notified to U.K.
cancerregistries overa two-yearperiod, four cases
were discovered (85), but only one of them is
considered acceptable as a sarcoma that could have
arisen in response to iron injection (86). The possi-
bility that iron dextran injection may give rise to
sarcoma cannot be entirely discounted, but the risk
(if any) appears to be extremely small.
Theadministrationofironoxidetotherespiratory
tract of hamsters by intratracheal instillation to-
getherwith benzo(a)pyrene orbyinhalation follow-
ing systemic administration of diethyl nitrosamine
has resulted in an increased yield oftumors, while
tumors were not obtained with iron oxide alone.
This effect is considered to be nonspecific.
An excess mortality from lung cancer has been
observed in iron ore miners from a number of
countries. The original observations were reported
from Cumberland, England (87), and confirmed in a
later study in 1970, in which the miners of haema-
tite showed a clear excess mortality from lung
cancer compared with national and regional figures
(88). An excess lung cancermortality has also been
reported amongst iron ore miners from some other
countries (89-93).
The increased lung cancer risk in haematite
miners may be attributed to a number of possible
factors. Although acarcinogenic effectofiron oxide
Environmental Health Perspectivesparticles alone, possibly actingin anonspecific way,
cannot be entirely discounted, the totality of the
evidence strongly suggests that the excess lung
cancer risk could be attributed to ionizing radiation
from the radon and radon daughters present in the
atmosphere of the mine. The relationship between
the excess mortality from lung cancer and the level
of radiation in the Cumberland haematite mines
was comparable to that found in other mining
situations where radioactivity is held to be respon-
sible for an occupational lung cancer risk (88).
However, radioactivity levels have not been de-
termined in all othermineswhere anincreased lung
cancer risk has been shown to exist.
Two early studies in Britain showed an increased
lung cancer mortality in foundry workers (94, 95),
but this cannot necessarily be attributed to iron
oxide, as exposure to polycyclic hydrocarbons also
occurred.
Lead
Inorganic lead has been shown to produce renal
tumors in a number of experimental studies, at
least six in rats (96-100) and one in mice (103).
Dosage was by several routes including oral. Lev-
els ofexposure in all ofthe studies farexceeded the
maximum doses tolerated by man and caused gross
morphologicaldamage tothekidney. Leadisreported
tohave produced lungtumors inhamsters (104) and
cerebral gliomas in rats (101). In vitro, lead oxide
has been found to induce dose-related transforma-
tion in Syrian hamster embryo cells (105). Lead
oxide also enhanced the transformation produced in
Syrian hamster cells by SA7 virus (106).
In an early epidemiological study, an excess
proportionate mortality ratio was noted for malig-
nant neoplasms (all sites combined) in battery
workers with so-called "negligible exposure with
lead in urine values within the normal range" (25
deaths observed vs. 14.2 expected; p < 0.05), but
no excess mortality was noted amongworkers with
"heavy" exposure to lead (107). No comment was
madeinthatstudyastoany site-specific occurrence
of excess malignancy.
In a more recent study of lead smelter and
battery workers (108, 109), a significant excess of
malignancies at all sites combined was found in
smelter workers but not in battery workers. In
bothgroups, mortality fromdigestiveandrespiratory
cancerwas greaterthan nationalrates predicted. A
five-year follow-up study leaves the interpretation
of these findings in doubt. This pattern was not
maintained, malignant neoplasms showing a slight
deficiency in smelters and slight excess in battery
workers (109, 110).
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From the data it may be concluded that there is
evidence that lead in high dose can produce cancer
in experimental animals. However, insufficient ob-
servations on man have been reported to enable a
definite conclusion to be reached as to whether lead
causes human cancer.
Nickel
Nickel is used chiefly in the production of alloys
including stainless steels. Other uses include:
electroplating, catalysts, coinage, and pigments.
Nickel alloys are also used injewelry and in dental
and surgical prostheses.
Occupational exposure occurs inmining, refining,
alloy production and use, electroplating, welding,
and in the handling ofnickel salts. Increased risk of
lung and nasal sinus cancer in nickel refining
workers was first noted in 1926 from Clydach,
Wales (111), a refinery using the Mond process
which began operation in 1902. The Mond process
made use ofnickel carbonyl inthe refiningofnickel.
Because of this, it has often been believed that
nickel carbonyl was the sole carcinogen. Subse-
quent epidemiological studies from Canada (112,
113), Norway (114, 115), the U.S.S.R. (72), and
New Caledonia (116) have shown that the increased
risk also occurred in refineries where the Mond
process was not used. In addition, continuing
studies have shown that the increased risk at the
Clydach refinery has dropped markedly in workers
entering employment after 1932 despite continuing
use ofthe carbonylprocess (111). Studies in Canada
(102, 113) and in Wales (111, 117) suggest that
exposure to furnace fumes and dusts from the high
temperature sintering or calcining ofimpure nickel
sulfide mattes was the source ofthe increased risk.
These same operations were carried out in the
Norwegian refinery (118) and, although some risk
appeared to be associated in the electrolytic work-
ers, mixed exposures of these workers cannot be
ruled out. The Norwegian studies also demon-
strated an increase in the observed incidence of
laryngeal cancer, as well as an increase in incidence
of lung and nasal sinus cancer.
Mining, smelting, and refining of laterite (nickel
oxide) ores have been carried out for about 100
years. It was believed that the increased risk of
respiratory cancer did not occur in laterite opera-
tions. Asinglecase-controlstudy,however,reported
an increase among workers and residents living
near a nickel smelter in New Caledonia (116). It
was also assumed that increased risk ofrespiratory
cancer did not occur among nickel users, e.g., in
nickel alloy manufacture and use, use of nickel
powder, nickel plating, nickel welding, etc., but
15definitive studies on this have been lacking. A
recentstudydidnotindicateanincreaseinrespiratory
cancer among a cohort exposed to nickel powder
and followed for a minimum of 19 years (119).
Another recent case control study did not indicate
an increase ofrisk in workers engaged in grinding
and welding operations with nickel alloys (120).
Studies with experimental animals have demon-
strated that nickel subsulfide (Ni3S2) produced local
tumors at a wide variety of injection sites and by
inhalation in rats (121). Ni3S2 also enhanced the
carcinogenic effects of benzo(a)pyrene (122) and
20-methylcholanthrene in experimental animals
(123). In vitro mammalian cell tests demonstrate
that Ni3S2 and NiSO4 compounds give rise to
mammalian cell transformation (124-130).
Other Metals
Epidemiological evidence relating to exposure to
a variety of other metals should be sought if at all
possible, either because large numbers ofworkers
are involved or because laboratory tests suggest
the possibility that a cancer hazard might exist.
These metals include copper, manganese, mercury,
platinum, selenium, titanium, vanadium, and zinc.
Studies of copper refiners are particularly desir-
able, but it may be difficult to define groups who
have not also had material exposure to arsenic.
In view of the small numbers of workers ex-
posed, it will be necessary to obtain the collabora-
tion of industry on an international scene if any
worthwhile human evidence is to be obtained relat-
ing to platinum, selenium, and vanadium. The
possibility of establishing specialized registers of




The epidemiological evidence strongly implicates
inorganic trivalent arsenic as the responsible agent
when an excess of lung cancer is attributed to
exposure to arsenic. There is, however, no reason
to exonerate pentavalent arsenic, and workers
exposed solely to other forms of arsenic should be
investigated further.
Experimental work should be undertaken on the
effect ofexposure oftherespiratory tract to arsenic
compounds of low solubility.
The incidence oflungcancerin areas where there
are unusually high concentrations of arsenic in the
air should be studied in order to assess possible
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risks to the general public. Airborne levels and
personal excretion patterns should be monitored in
such areas.
There is a need to study dose-response relation-
ships for arsenic in water and skin cancer. Particu-
lar emphasis should be given to differences in
relation to valence state.
The conclusion that beryllium and cadmium con-
tribute to the development ofsome cancers in man
was reached because this seemed to be the most
reasonableinterpretation oftheavailablefacts. The
numbers ofobservations on man are small, howev-
er, in both cases, and it is important to check that
the conclusion is correct by continued observation
of the cohorts of workers exposed to beryllium in
the U.S. and by collecting observations on larger
numbers ofmenwhohave beenexposed to substan-
tial amounts of cadmium whenever they can be
found.*
Further studies are required to determine which
compounds of chromium are carcinogenic to man
and, particularly, to determine if there is any
hazard associated with exposure to soluble com-
pounds in the plating industry.
Cohorts ofworkers exposed to airborne respira-
ble cobalt and its inorganic compounds should be
identified and followed uptodetermine theircancer
mortality rates.
Long-term exposure of experimental animals to
both insoluble and soluble forms of cobalt (such as
cobalt oxide or cobalt sulfide and cobalt chloride or
cobalt nitrate) via the respiratory tract should be
included.
Further epidemiological studies of iron miners,
steel workers, foundry workers, and welders are
required in which attempts are made to character-
ize the extent to which the men are exposed to
ionizing radiation and possible carcinogens as well
as to iron and iron compounds.
More studies are needed of men who have had
long term occupational exposures to lead. Case-
control studies of adults with kidney tumors and
follow-up studies of people who suffered from lead
poisoning in childhood could also help to clarify the
extent to which lead may contribute to the devel-
opment of cancer in man.
Further epidemiological studies of workers ex-
posed to soluble and slightly soluble forms ofnickel
and nickel alloys in the nickel processing and
mining industries are needed.t These should in-
* Alargerepidemiological studyofcadmiumworkers iscurrently
being carried out in Britain, the results of which should be
available in 1982.
tMany such studies are currently underway, the results of
which should become available in 1981.
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and other metals, e.g., nickel and cadmium in
battery manufactures and nickel and chromium in
stainless steel manufactures, welding, nickel plat-
ing, and chrome plating.
Additional long-term inhalation studies in exper-
imental animals are needed to determine the poten-
tial carcinogenicity of nickel metal and nickel com-
pounds. Priority should be given to testing nickel
metal, nickel sulfate, and nickel oxide, because of
the large number of workers exposed and the lack
of conclusive information concerning these sub-
stances.
General
The possibility of interactions between metals
(particularly arsenic), other industrial pollutants
and tobacco smoke in the production oflung cancer
should be further investigated.
Epidemiological studies should, whenever prac-
tical, include comparison of the risk of cancer in
groups ofindustrial workers exposed to aparticular
agent with that in unexposed workers in the same
industry or in residence in the same geographical
areaas well as with those in the country as awhole.
In epidemiological studies, identification of co-
horts with past exposure is often difficult or impos-
sible because: (a) employment records are often
destroyed after a minimal time interval, and (b)job
descriptions in company or medical records may be
nonexistent or inadequate. Employment records
adequate for the identification of workers for the
determination oftheir vital studies should be retained
by companies and medical or industrial hygiene
departments where these exist for a minimum of30
years. Because of the long period that may elapse
between initial exposure and the development of
cancer, these records should include job descrip-
tion, with qualitative and quantitative information
on exposure. Whenever possible, information on
other potential exposures, e.g., cigarette smoking,
should be recorded.
In the interest of public health, facilities should
be provided in all industrialized countries to allow
bonafideresearchworkerstolinkrecordsmaintained
in industry with national records of birth (when
practicable), sickness, and causes of death, subject
to appropriate safeguards to insure that personal
records are never used to the detriment of the
individual.
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